The PE Ratio as of December 2025 (TTM) for Immuno-Biological Laboratories Co., Ltd. (4570.T) is 40.65

According to Immuno-Biological Laboratories Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 40.65. This represents a change of 69.62% compared to the average of 23.97 of the last 4 quarters.

Immuno-Biological Laboratories Co., Ltd. (4570.T) Historical PE Ratio (quarterly & annually)

How has 4570.T PE Ratio performed in the past?

The mean historical PE Ratio of Immuno-Biological Laboratories Co., Ltd. over the last ten years is -0.73. The current 40.65 PE Ratio has changed -554158.57% with respect to the historical average. Over the past ten years (40 quarters), 4570.T's PE Ratio was at its highest in in the September 2023 quarter at 83.81. The PE Ratio was at its lowest in in the December 2023 quarter at -182.99.

Immuno-Biological Laboratories Co., Ltd. (4570.T) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Immuno-Biological Laboratories Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Immuno-Biological Laboratories Co., Ltd. (4570.T) Average PE Ratio

How has 4570.T PE Ratio performed in the past?

The current PE Ratio of Immuno-Biological Laboratories Co., Ltd. (4570.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Immuno-Biological Laboratories Co., Ltd. (4570.T) PE Ratio vs. Peers

How is 4570.T’s PE Ratio compared to its peers?

Immuno-Biological Laboratories Co., Ltd.’s PE Ratio is greater than Carna Biosciences, Inc. (-2.15), greater than Delta-Fly Pharma, Inc. (-3.35), greater than Ribomic Inc. (-3.46), greater than Soiken Holdings Inc. (-31.58), greater than D. Western Therapeutics Institute, Inc. (-4.32), greater than FunPep Company Limited (-2.48), greater than Human Metabolome Technologies, Inc. (14.75), greater than Living Platform,Ltd. (11.74), greater than Kubota Pharmaceutical Holdings Co., Ltd. (-2.61), greater than Perseus Proteomics Inc. (-5.00),

Build a custom stock screener for Immuno-Biological Laboratories Co., Ltd. (4570.T) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immuno-Biological Laboratories Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immuno-Biological Laboratories Co., Ltd. (4570.T) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immuno-Biological Laboratories Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.